New research suggests that widely prescribed weight-loss medications could have an unexpected impact on cancer treatment, potentially influencing tumor growth or response to therapies. Studies indicate these drugs may alter metabolic pathways linked to certain cancers, raising questions about their broader implications for patients. While further investigation is needed, the findings highlight a possible connection between obesity treatments and oncology. Experts are now examining whether these medications could offer additional benefits—or risks—for cancer patients.
Popular weight-loss drugs may play surprising role in cancer outcomes Fox News
